MedPath

OM and Trauma Study

Early Phase 1
Not yet recruiting
Conditions
PTSD
Interventions
Behavioral: Orgasmic Meditation
Registration Number
NCT05577377
Lead Sponsor
Institute of OM Foundation
Brief Summary

The primary purpose of this study is to use an unblinded, uncontrolled, 1-month interventional single group pilot study, to assess the possibility of Orgasmic Meditation practice being used as a possible intervention for PTSD. The secondary purpose of this study is to examine if OM is associated with a decrease in the symptoms and self-assessed experiences associated with trauma.

The OM Trauma Protocol (OMTP) is designed to systematize the application of Orgasmic Meditation (OM) for individuals seeking relief from a wide variety of problems and/or help them in their pursuit of eudaimonia. The study protocol will evaluate whether OMing (the act of practicing OM) shows potential for being an effective intervention for people suffering from Post-Traumatic Stress Disorder (PTSD).

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Adults ≥18 years old
  • One or more participants of the pair having a diagnosis of PTSD for > 6 months
  • Relationship for > 6 months
  • Self or partner of female sex
  • Massachusetts residents
  • Access and ability to use internet and a video platform called Zoom
  • No history of doing the practice of OM
Exclusion Criteria
  • Ongoing or active use of illicit drugs at the time of the study
  • Self-identify as pregnant
  • Inability to speak English
  • Recent hospitalization < 12 months
  • Suicidal ideation < 12 months
  • Self-harm < 12 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
OM interventionOrgasmic Meditation-
Primary Outcome Measures
NameTimeMethod
Correlation between OM and PTSD symptoms4 weeks

Change in PCL-5 Score

Number of participants who withdraw from the study4 weeks

Safety will be measured by completion rate

Number of participants who score a 39 or higher using the OM perceived value survey4 weeks

feasibility measured by OM perceived value survey

Secondary Outcome Measures
NameTimeMethod
Correlation between depression and OM4 weeks

Changes in The Patient Health Questionnaire: Depression Scale (PHQ-9)

Correlation between anxiety and OM4 weeks

Changes in the Generalized Anxiety Disorder 7-Item Scale (GAD-7)

Correlation between Eudaimonia and OM4 weeks

Changes in Eudaimonia Assessment

Correlation between psychosocial functioning and OM4 weeks

Changes in The Brief Inventory for Psychosocial Functioning (B-IPF)

Trial Locations

Locations (1)

Institute of OM Foundation

🇺🇸

Santa Rosa, California, United States

© Copyright 2025. All Rights Reserved by MedPath